Semax
ACTH(4-10)-derived heptapeptide. Approved in Russia for stroke/cognitive research.
Neuroregulation Research Peptides
N-Acetyl Selank Amidate carries dual N-acetyl and C-amide terminal modifications on the Selank backbone, intended to improve proteolytic stability and blood-brain-barrier penetrability relative to the parent peptide. It is supplied as a research-grade probe for anxiolytic and neuroplasticity signaling studies; unlike Selank, it holds no independent clinical approval.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
ACTH(4-10)-derived heptapeptide. Approved in Russia for stroke/cognitive research.
N-acetylated, stability-enhanced Semax derivative.
Tuftsin-derived heptapeptide. Approved in Russia for anxiety.